Vancomycin Dosing and Monitoring in the Treatment of Cystic Fibrosis: Results of a National Practice Survey

OBJECTIVES: Vancomycin is commonly used in patients with cystic fibrosis (CF) to treat acute pulmonary exacerbations, but few guidelines exist to help dose and monitor patients. The objective of this study was to assess vancomycin use and monitoring strategies at Cystic Fibrosis Foundation (CFF)–acc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pediatr Pharmacol Ther
Autori principali: Pettit, Rebecca S., Peters, Stacy J., McDade, Erin J., Kreilein, Kaci, Patel, Radha, Epps, Kevin, Kittell, Frederick, Duval, Mariela A., Zobell, Jeffery T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pediatric Pharmacy Advocacy Group 2017
Soggetti:
Clinical Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736252/
https://ncbi.nlm.nih.gov/pubmed/29290740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-22.6.406
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi